Advanced photon source helps Pfizer create COVID-19 antiviral treatment
The patently obvious need to protect COVID-19 vaccine intellectual property
8 November 2021Reactivation in the hippocampus could support the consolidation of long-term cognitive maps
8 November 2021Advanced photon source helps Pfizer create COVID-19 antiviral treatment
Pharmaceutical company Pfizer has announced the results of clinical trials of its new oral antiviral treatment against COVID-19. The new drug candidate, Paxlovid, proved to be effective against the SARS-CoV-2 virus, which causes COVID-19, according to results released by Pfizer on Nov. 5.
